NPI registry status
Active
2026 NPPES data Gastroenterology Physician NPI 1679527485 MD
Verify on CMS → Mark Moglowsky, MD
Gastroenterology Physician in Huntsville, Alabama.
This profile is drawn from the federal National Provider Identifier Registry (CMS NPPES), which lists more than 7 million U.S. healthcare providers - including 16,567 in Gastroenterology Physician, and covers specialty classification, practice address, and Medicare Part D prescribing data when reported. According to CMS, every field reflects the provider's official federal registration, see our methodology.
Federal data, no proprietary rating.
We show these CMS records as-is - no composite score, no star rating, no editorial opinion layered on top.
Prescribing volume
908
Medicare Part D claims · 334 beneficiaries · Gastroenterology Physician avg: 833
Generic prescribing
77%
generic claims · 23% brand-name · higher generic rates reduce patient out-of-pocket costs
MIPS score
75/100
▼ 8 pts below national avg 83.1 · Above neutral
Industry payments
$16.51
1 payments · CMS Open Payments (Sunshine Act)
Source: CMS Medicare Part D Prescriber Public Use File, 2023
Compiled from official public sources by the PlainDoctor editorial team.
What the federal data shows
Mark Moglowsky, MD reported a CMS MIPS final score of 75/100 - below the 83.1 national average - and filed 908 Medicare Part D claims in 2023.
- 75/100
- MIPS score · -8 vs avg
- 908
- Part D claims, 2023
- 77%
- generic prescribing
- Likely
- board-certified (heuristic)
Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) - no proprietary rating or editorial opinion is applied.
Mark Moglowsky, MD's MIPS score vs every scored U.S. clinician
CMS Merit-based Incentive Payment System (MIPS) final score, 2023, the federal quality measure
75 15th percentile higher than 15% of 477,587 scored providers
Each bar is a band; taller bars hold more scored providers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source CMS Merit-based Incentive Payment System (MIPS) · 2023
Where Mark Moglowsky, MD sits
This provider among gastroenterology physician peers
Across the 5,957 gastroenterology physician providers who report both Medicare Part D prescribing and a MIPS quality score, Mark Moglowsky, MD writes more Part D claims than 57% of them and scores higher on MIPS quality than 12% - placing this provider in the high-volume, lower-quality quadrant. Volume reflects patient-panel size and specialty, not quality; the two axes are independent.
Part D claim volume vs MIPS quality, by specialty percentile
Each dot is one gastroenterology physician peer from a representative sample of 60; the gold marker is Mark Moglowsky, MD. Source: CMS Medicare Part D Prescriber data and the CMS Merit-based Incentive Payment System, 2023.
✓
Board certification likely (heuristic, not verified)
Mark Moglowsky, MD practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + MIPS quality reporting - signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).
What does the federal data show about Mark Moglowsky, MD?
Below national averagePrimary specialty
Gastroenterology Physician
Medicare Part D claims
908 9% vs specialty avg
MIPS final score
75/100 8.1 pts vs avg
Specialty distribution in Alabama
How Gastroenterology Physician compares to other specialties among Alabama providers
Medicare quality performance, MIPS
Mark Moglowsky, MD's 2023 MIPS final score plotted against the Gastroenterology Physician national average
- MIPS Final Score
- 75/100
- vs 83.1 national avg · 2023 performance year
MIPS final score (Gastroenterology Physician) - 75/100 vs national avg 83.1
How MIPS and board certification work
The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.
Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).
Mark Moglowsky, MD appears in the CMS NPPES registry as a Gastroenterology Physician provider holding MD credentials at 119 LONGWOOD DR SW, Huntsville, AL, 35801, with a listed phone of (256) 533-6488. NPI 1679527485 was issued on 05/19/2006.
Medicare Part D records for calendar year 2023 show 908 prescription claims written by this provider, covering 334 Medicare beneficiaries and totaling roughly $235K in drug spend, split 23% brand-name and 77% generic by claim count. On the CMS Merit-based Incentive Payment System, this provider earned a Final Score of 75/100 for the 2023 performance year, compared with the national average of 83.1.
Gastroenterology Physician is a mid-sized specialty nationwide, with 16,567 enrolled providers across 54 states and an average of 833 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline.
Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist, always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.
Practice Address
Provider Details
| NPI | 1679527485 |
|---|---|
| Specialty | Gastroenterology Physician |
| Credentials | MD |
| Gender | Male |
| NPI Issued | 05/19/2006 |
CMS Quality Score (MIPS)
Merit-based Incentive Payment System (MIPS) scores from CMS, 2023 performance year.
75
Final Score
Avg: 83.1
Reporting: Group practice
Industry payments received (2024) - CMS Open Payments transparency data
The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for Mark Moglowsky, MD. Source: openpaymentsdata.cms.gov.
Total received
$17
Largest payer
Micro-tech Endoscopy USA, Inc.
Most common payment type
Food and Beverage
Industry payments are not necessarily indicators of bias, they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.
Brand vs generic prescribing mix · Typical
Mark Moglowsky, MD - brand share 23.0%
Gastroenterology Physician average
23% brand-name claims vs 77% generic, on 908 2023 Medicare Part D claims.
The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.
Medicare Part D Prescribing Data
CMS Medicare Part D prescriber-level data for calendar year 2023.
908
Total Claims
$235K
Total Drug Cost
334
Medicare Beneficiaries
Prescribing Breakdown
- 30-Day Fills
- 1,565
- Total Day Supply
- 42,026
- Brand vs Generic
- 23% brand / 77% generic
- Brand Drug Cost
- $193K
- Generic Drug Cost
- $42K
- Antibiotic Claims
- 45
Patient Demographics
- Average Patient Age
- 71.0 years
- Avg HCC Risk Score
- 1.22
- Gender Split
- 60% female / 40% male
- Age Distribution
- <65: 57, 65-74: 152, 75-84: 106, 85+: 19
Top Prescribed Drugs (Medicare Part D)
Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.
What Mark Moglowsky, MD prescribes most
Top Medicare Part D drugs by claim count, 2023
- Pantoprazole Sodium
Pantoprazole Sodium
264 claims
- Omeprazole 69
Omeprazole
69 claims
- Famotidine 57
Famotidine
57 claims
- Ondansetron Odt 28
Ondansetron Odt
28 claims
- Clenpiq 26
Clenpiq
26 claims
- Linzess 25
Linzess
25 claims
- Peg 3350-Electrolyte 24
Peg 3350-Electrolyte
24 claims
- Lactulose 23
Lactulose
23 claims
| Drug | Claims |
|---|---|
| Pantoprazole Sodium | 264 |
| Omeprazole | 69 |
| Famotidine | 57 |
| Ondansetron Odt Ondansetron | 28 |
| Clenpiq Sod Picosulf/Mag Ox/Citric Ac | 26 |
| Linzess Linaclotide | 25 |
| Peg 3350-Electrolyte Sodium Chloride/Nahco3/Kcl/Peg | 24 |
| Lactulose | 23 |
| Esomeprazole Magnesium | 20 |
| Mesalamine | 20 |
* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.
Gastroenterology Physician Overview
How Mark Moglowsky, MD fits within the Gastroenterology Physician landscape nationally.
16,567
Gastroenterology Physician Providers in US
54
States with Gastroenterology Physician
833
Avg Claims per Provider
Mark Moglowsky, MD's 908 claims are above the specialty average of 833.
Nearby Gastroenterology Physician Providers in Alabama
Other clinicians with the same primary specialty enrolled in Alabama, drawn from the same CMS NPPES roster as Moglowsky.
Dr. Sam Abdehou
MD
Mobile, AL
Dr. Rishi Agarwal
M.D.
Birmingham, AL
Dr. Patricia Ajayi-Fox
M.D.
Birmingham, AL
Dr. Robert Albares
MD
Dothan, AL
Dr. Francisco Alcocer
MD
Birmingham, AL
Compare Gastroenterology Physician nationally: see state-by-state distribution →
Before you book an appointment
Use this federal record as your verification checklist, not as a recommendation.
- Confirm the NPI record is current in the official CMS registry, providers update their own NPPES details, and moves can lag. Verify this NPI
- Check the active license and any disciplinary history with the Alabama medical board, federal registration is not a license check. Credential verification guide
- Weigh a second option: compare this provider with a nearby Gastroenterology Physician peer on Medicare volume and prescribing patterns. Compare providers
Medicare Part D and MIPS figures describe practice patterns in federal programs only, they are not quality ratings, and PlainDoctor does not rate, rank, or recommend providers.
Healthcare Guides
Learn more about finding, verifying, and understanding healthcare providers.
How to Find a Doctor
Step-by-step guide to choosing a provider
Verify Credentials
Check NPI, board certification & license status
Medical Specialties Explained
Who treats what and how specialties differ
Understanding Medicare Claims Data
What prescribing data reveals about a provider
In-Network vs Out-of-Network
How insurance networks affect your costs
Telehealth Guide
Virtual care options and coverage in 2026
Explore Alabama
Frequently Asked Questions
What is Mark Moglowsky, MD's specialty? ▼
Mark Moglowsky, MD specializes in Gastroenterology Physician and practices in Huntsville, Alabama. Credentials: MD.
How much does Mark Moglowsky, MD prescribe under Medicare Part D? ▼
In 2023, Mark Moglowsky, MD wrote 908 Medicare Part D claims totaling $235K in drug costs for 334 beneficiaries.
What is Mark Moglowsky, MD's Medicare quality score? ▼
Mark Moglowsky, MD has a CMS MIPS Final Score of 75/100. The national average MIPS Final Score is 83.1. Source: CMS Merit-based Incentive Payment System (MIPS) 2023.
Where is Mark Moglowsky, MD located? ▼
Mark Moglowsky, MD is located at 119 LONGWOOD DR SW, Huntsville, AL, 35801. Phone: (256) 533-6488.
What is Mark Moglowsky, MD's NPI number? ▼
Mark Moglowsky, MD's National Provider Identifier (NPI) is 1679527485, issued on 05/19/2006.
Does Mark Moglowsky, MD prescribe more brand-name or generic drugs? ▼
Mark Moglowsky, MD's prescribing is 23% brand-name and 77% generic drugs by claim count, with $193K in brand drug costs.
How many Gastroenterology Physician providers are there in the US? ▼
There are 16,567 Gastroenterology Physician providers across 54 states in the US. The average Gastroenterology Physician provider writes 833 Medicare Part D claims per year.
What drugs does Mark Moglowsky, MD prescribe most often? ▼
Based on 2023 Medicare Part D data, Mark Moglowsky, MD's most frequently prescribed drugs include Pantoprazole Sodium, Omeprazole, Famotidine. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does Mark Moglowsky, MD accept Medicare? ▼
Mark Moglowsky, MD appears in CMS Medicare data with 908 Part D claims and 334 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify Mark Moglowsky, MD's credentials? ▼
Mark Moglowsky, MD's NPI is 1679527485 with credentials MD. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.
Data Sources
View source datasets and methodology notes
- Provider Directory
- CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
- Specialty Classification
- NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
- Prescribing Data
- CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
- Quality Performance
- CMS Merit-based Incentive Payment System (MIPS) - 2023 performance year.
- Limitations
- Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.
See our complete data methodology for details on how we collect and process government data.
Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).
Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology
Compiled from official public sources by the PlainDoctor editorial team.